Abstract:Suicide rates have increased steadily world-wide over the past two decades, constituting a serious public health crisis that creates a significant burden to affected families and the society as a whole. Suicidal behavior involves a multi-factorial etiology, including psychological, social and biological factors. Since the molecular neural mechanisms of suicide remain vastly uncharacterized, we examined transcriptional- and methylation profiles of postmortem brain tissue from subjects who died from suicide as well as their neurotypical healthy controls. We analyzed temporal pole tissue from 61 subjects, largely free from antidepressant and antipsychotic medication, using RNA-sequencing and DNA-methylation profiling using an array that targets over 850,000 CpG sites. Expression of NPAS4, a key regulator of inflammation and neuroprotection, was significantly downregulated in the suicide decedent group. Moreover, we identified a total of 40 differentially methylated regions in the suicide decedent group, mapping to seven genes with inflammatory function. There was a significant association between NPAS4 DNA methylation and NPAS4 expression in the control group that was absent in the suicide decedent group, confirming its dysregulation. NPAS4 expression was significantly associated with the expression of multiple inflammatory factors in the brain tissue. Overall, gene sets and pathways closely linked to inflammation were significantly upregulated, while specific pathways linked to neuronal development were suppressed in the suicide decedent group. Excitotoxicity as well as suppressed oligodendrocyte function were also implicated in the suicide decedents. In summary, we have identified central nervous system inflammatory mechanisms that may be active during suicidal behavior, along with oligodendrocyte dysfunction and altered glutamate neurotransmission. In these processes, NPAS4 might be a master regulator, warranting further studies to validate its role as a potential biomarker or therapeutic target in suicidality.

A Unique Gene Expression Signature Associated with Serotonin 2C Receptor RNA Editing in the Prefrontal Cortex and Altered in Suicide.

Altered serotonin 2C receptor RNA splicing in suicide: association with editing

Gene expression changes in the prefrontal cortex, anterior cingulate cortex and nucleus accumbens of mood disorders subjects that committed suicide

Prefrontal Alterations in GABAergic and Glutamatergic Gene Expression in Relation to Depression and Suicide.

Whole-transcriptome brain expression and exon-usage profiling in major depression and suicide: evidence for altered glial, endothelial and ATPase activity

Integrative analyses of scRNA-seq, bulk mRNA-seq, and DNA methylation profiling in depressed suicide brain tissues

Epigenetic regulation of spermidine/spermine N1-acetyltransferase (SAT1) in suicide

Different stress-related gene expression in depression and suicide

Brain transcriptomic signatures for mood disorders and suicide phenotypes: an anterior insula and subgenual ACC network postmortem study

Integrative transcriptome- and DNA methylation analysis of brain tissue from the temporal pole in suicide decedents and their controls

Association of the Htr2a 102t/c Polymorphism with Attempted Suicide: A Meta-Analysis

Altered transcriptomes, cell type proportions, and dendritic spine morphology in hippocampus of suicide decedents

Brain and blood transcriptome profiles delineate common genetic pathways across suicidal ideation and suicide

Methylation and expression of glucocorticoid receptor exon-1 variants and FKBP5 in teenage suicide-completers

Genome-wide methylome-based molecular pathologies associated with depression and suicide

Network-based approach to identify molecular signatures in the brains of depressed suicides

Transcriptomic analysis of postmortem brain identifies dysregulated splicing events in novel candidate genes for schizophrenia.

Epigenetics and suicide: investigating altered H3K14ac unveiled differential expression in ADORA2A, B4GALT2 and MMP14

Serotonergic gene expression and depression: implications for developing novel antidepressants

Transcriptomics and sequencing analysis of gene expression profiling for major depressive disorder

Brain Epitranscriptomic Analysis Revealed Altered A-to-I RNA Editing in Septic Patients